Weston Nichols, 10% Owner at TScan Therapeutics, Inc. (TCRX), bought 100,000 shares at $2.90 ($290K) on 2024-12-13, disclosed to the SEC on 2024-12-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| TCRX | BUY | 2024-11-19 | $4K | — | Filing → |